Cesar Poli | Biopharmaceutics | Innovative Research Award

Published on by Top Pharmaceutical

Innovative Research Award

Cesar Poli – Federal University of Rio Grande do Sul, Brazil

Cesar Poli
Affiliation Federal University of Rio Grande do Sul
Country Brazil
Scopus ID 13408393000
Documents 56
Citations 719
h-index 16
Subject Area Biopharmaceutics
Event International Top Pharmaceutical Awards
ORCID 0000-0002-8469-0779

Cesar Poli is a researcher and Associate Professor at the Federal University of Rio Grande do Sul (UFRGS), Brazil. His documented academic profile includes training in Agronomy, Animal Science and Pastoral Science, together with research activity involving sheep production, pasture management, production systems and ruminant nutrition. His ORCID record also identifies continuing academic employment at UFRGS and international research collaborations. [1]

Abstract

The Innovative Research Award profile recognizes the documented scholarly activities of Cesar Poli and presents his research record in an academic context. Available profile information records his association with UFRGS, postgraduate education, international collaborations, publication activity and peer-review participation. His research portfolio includes pasture-based production, sheep management, ruminant nutrition, animal behaviour and plant bioactive compounds. [1]

Keywords

Keywords: Cesar Poli, Innovative Research Award, Biopharmaceutics, Animal Science, Ruminant Nutrition, Pasture Management, Sheep Production, Grazing Systems, Plant Bioactive Compounds, Animal Behaviour, Livestock Research, Pharmaceutical Research.

Introduction

Cesar Poli’s academic career is associated with the Federal University of Rio Grande do Sul, where the ORCID record identifies him as an Associate Professor in Animal Science. His educational history includes an Agronomy degree from UFRGS, postgraduate study in Animal Science/Pastoral Science, and a Ph.D. from Massey University. These qualifications provide the documented foundation for his subsequent research and teaching activities. [1]

Research Profile

The available record describes research centered on the animal-plant interface, sheep production and management, production systems, pasture management, and integrated production and nutrition systems for ruminants. Recent publications address grazing intensity, tropical grass and legume pastures, tannins, lamb performance, animal behaviour and pasture characteristics. [2] [3]

Research Contributions

Poli’s publication record demonstrates sustained investigation of pasture-based livestock systems and nutritional factors affecting ruminant production. His documented studies include work on plant tannins, lamb growth, pasture structure, dietary preference and meat quality. A 2025 publication specifically examined plant tannin for grazing ruminant growth, while another investigated tropical grass and legume pastures grazed by lambs. [3] [4]

Publications

Cesar Poli has published research on pasture management, sheep production, ruminant nutrition, grazing behaviour, and plant bioactive compounds. His documented publications span recent studies and long-term research contributions in animal and pasture science. The research also covers lamb performance, pasture characteristics, dietary preference, and meat quality. His publication record demonstrates sustained scholarly engagement across animal science and related agricultural research areas. [1]

Research Impact

The supplied profile reports 56 documents, 719 citations and an h-index of 16 for the researcher. These bibliometric indicators provide quantitative measures of publication and citation activity, although they should be interpreted alongside disciplinary context, publication type and research collaboration. The ORCID record also documents international projects involving researchers and institutions across several countries. [1]

Award Suitability

For the International Top Pharmaceutical Awards, the Innovative Research Award profile can be considered in relation to the supplied subject classification of Biopharmaceutics and the researcher’s documented scientific record. His publications provide evidence of sustained research activity in biological production systems, nutrition, plant-derived compounds and animal science. Final award assessment should remain subject to the event’s formal evaluation criteria and independent review. [1]

Conclusion

Cesar Poli has a documented academic career at the Federal University of Rio Grande do Sul and a substantial publication record covering pasture management, sheep production, ruminant nutrition, animal behaviour and plant bioactive compounds. His ORCID record supports the chronology of his education, employment, research outputs and peer-review activity. These documented elements provide an academic basis for consideration within an innovation-focused recognition framework. [1]

References

  1. ORCID. (2026). Cesar Poli (0000-0002-8469-0779) – ORCID record. https://orcid.org/0000-0002-8469-0779
  2. Motta, J. H., Poli, C. H. E. C., Irigoyen, L. R., et al. (2026). Patterns of Plant Species Composition Under Different Grazing Intensity in Native Grasslands of Southern Brazil. Rangeland Ecology and Management. https://doi.org/10.1016/j.rama.2025.12.008
  3. Hampel, V. D. S., Poli, C. H. E. C., Tontini, J. F., et al. (2025). Physical and biochemical characteristics of tropical grass and legume pastures grazed by lambs. Grassland Science. https://doi.org/10.1111/grs.12433
  4. Poli, C. H. E. C., Tontini, J. F., Jacondino, L. R., et al. (2025). Plant tannin for grazing ruminant growth. Animal Frontiers. https://doi.org/10.1093/af/vfaf026
  5. Jacondino, L. R., Poli, C. H. E. C., Tontini, J. F., Correa, G., da Silva, I., Nigeliskii, A., Mello, R., Pereira, A., Magalhães, D., & Trindade, M., et al. (2024). Plant Bioactive Compounds of Brazilian Pampa Biome Natural Grasslands Affecting Lamb Meat Quality. Foods, 13(18), 2931. https://doi.org/10.3390/foods13182931

Onwu Daniel Ocha | Drug Discovery | Best Researcher Award

Published on by Top Pharmaceutical

Best Researcher Award

Onwu, Daniel Ocha
Affiliation University of Cross River State
Country Nigeria
Google Scholar ID n6jcvPsAAAAJ
Documents 9
Citations 2
h-index 1
Subject Area Drug Discovery
Event International Top Pharmaceutical Awards

Onwu Daniel Ocha – University of Cross River State

Onwu Daniel Ocha is a researcher affiliated with the University of Cross River State (UNICROSS), Calabar, Nigeria. His reported scholarly work is associated with computational biology, bioinformatics, drug discovery, network pharmacology, phytochemical investigation, and computational modelling. The supplied Google Scholar record reports nine documents, two citations, and an h-index of one. The profile also identifies computational biology and bioinformatics among the research areas associated with his scholarly activity.

Abstract

Onwu Daniel Ocha’s research profile reflects interdisciplinary activity connecting computational biology and bioinformatics with pharmaceutical and biomedical investigation. His available publication record includes research on phytochemicals, network pharmacology, computational modelling, biological targets, infectious diseases, and therapeutic investigation. These subjects are relevant to modern drug discovery because computational approaches can support the identification of candidate compounds, molecular targets, pathways, and potential mechanisms of action. His research record therefore demonstrates an emerging connection between computational science and pharmaceutical research. [1]

Keywords

Drug Discovery; Computational Biology; Bioinformatics; Network Pharmacology; Computational Modelling; Molecular Docking; Phytochemicals; Drug Target Identification; Systems Biology; Therapeutic Targeting; Pharmaceutical Research; In-silico Research; Biomedical Informatics.

Introduction

Computational biology and bioinformatics have become important components of modern pharmaceutical research. Computational approaches can be used to examine molecular interactions, biological pathways, disease-associated targets, and candidate therapeutic compounds before or alongside laboratory validation. Network pharmacology is particularly useful for studying complex relationships between compounds, proteins, pathways, and disease mechanisms. These approaches can contribute to the prioritization of potential therapeutic candidates and provide hypotheses for subsequent experimental research [1].

Research Profile

The supplied academic profile identifies Onwu Daniel Ocha with the University of Cross River State (UNICROSS), Calabar, Nigeria. His Google Scholar record reports nine documents, two citations, and an h-index of one. The research areas represented in the supplied profile include computational biology and bioinformatics, while the award profile specifically identifies Drug Discovery as the subject area. This combination places his research at the intersection of computational science and pharmaceutical investigation.[3]

Research Contributions

A notable contribution in the supplied publication record is the study titled In-Silico and Network Pharmacology Analysis of Mimosa invisa Phytochemicals against Testicular Inflammation. The work examines phytochemical compounds using computational approaches to investigate their potential relationships with inflammation-associated biological targets. This research direction is relevant to drug discovery because phytochemicals may provide candidate structures for further pharmacological investigation [3].

Publications

The available publication record demonstrates continuing scholarly activity in computational and biomedical research. Listed publications include studies on Mimosa invisa phytochemicals, biosynthesized silver nanoparticles, Terminalia catappa extracts, Allium cepa bioactive compounds, drug-resistant tuberculosis, Tefairia occidentalis phytocompounds, and computational analysis of antiviral targets. The diversity of these topics indicates an interdisciplinary research approach involving computational methods and biological investigation.[3].

Research Impact

The supplied Google Scholar profile reports two citations and an h-index of one. These bibliometric indicators represent the citation activity recorded by the profile at the time of the supplied document and may change as additional publications are indexed and cited. Therefore, citation indicators should be considered together with publication quality, research relevance, collaboration, and scientific contribution when assessing an emerging researcher.[4].

Award Suitability

The award assessment should nevertheless remain evidence-based and should consider the complete research portfolio, verified publication records, originality, methodological quality, scholarly contribution, collaboration, and the official eligibility criteria established by the award organizers. The available profile demonstrates an emerging publication record rather than providing sufficient evidence for unsupported claims of exceptional impact. This distinction maintains a neutral academic approach to recognition[4].

Conclusion

Onwu Daniel Ocha’s documented research profile demonstrates interdisciplinary activity involving computational biology, bioinformatics, drug discovery, network pharmacology, phytochemicals, and systems biology. The supplied record identifies nine documents, two citations, and an h-index of one, while the listed publications demonstrate research activity across several biomedical and pharmaceutical themes. [1].

References

  1. Onwu, D. O., Uraku, O. H., Agbi, M. T., & Uraku, A. J. (2026). In-silico and network pharmacology analysis of Mimosa invisa phytochemicals against testicular inflammation. In Silico Research in Biomedicine, 2, 100274.
    https://doi.org/10.1016/j.insi.2026.100274
  2. Onwu, D., Edun, S., Asuquo, U., & Bajepade, T. I. (2025). Antidiabetic potential of biosynthesized silver nanoparticles with fresh guava leaf. Covenant Journal of Physical and Life Sciences, 13(2), 1–6.
    https://journals.covenantuniversity.edu.ng/index.php/cjpls/article/view/4978
  3. Onwu, D. O., Kayode, D., Oluwatosin, C. E., Chimaobi, N. G., Johnson, O., et al. (2026). Assessing the effects of aqueous extract of Terminalia catappa on immunoglobulins levels in cyclophosphamide induced immunosuppressant Wistar rats. Next Research, 101441.
    https://doi.org/10.1016/j.nexres.2026.101441
  4. Onwu, D. O., Singh, A., Bajpai, Y., Akinlamilo, A. S., Habiganuchi, A., & Ibikunle, F. O. (2025). Host–pathogen interaction mapping in drug-resistant tuberculosis: A systems biology framework for dual therapeutic targeting. Research Square.
    https://doi.org/10.21203/rs.3.rs-7855974/v1
  5. Ahmad, A., Nnenna, A. O., Mamman, S., Nwokoro, C., Bello, A. M., Nseabasi, M. A., Abdulwakiil, M., Okpe, J., Onwu, D. O., Agbi, M., & Idoko, A. (2025). In-silico network pharmacology and computational modelling of bioactive compounds from Allium cepa targeting downstream protein effectors in diabetes. Research Square.
    https://doi.org/10.21203/rs.3.rs-8181479/v1

Chao Song | Drug Discovery and Development | Pharmaceutical Excellence Award 

Published on by Top Pharmaceutical

Mr. Chao Song | Drug Discovery and Development | Pharmaceutical Excellence Award 

Guangxi Traditional Chinese Medical University | China

Mr. Chao Song is a PhD researcher at Guangxi University of Traditional Chinese Medicine, specializing in pharmacology, molecular biology, and translational medicine. He holds advanced academic training in biomedical sciences with a focus on traditional Chinese medicine and intervertebral disc disorders. His professional experience includes active participation in multiple provincial and municipal research projects, demonstrating strong collaborative and leadership capabilities in scientific investigations. His research primarily explores intervertebral disc degeneration, immune regulation, cellular senescence, and multi-omics integration, with contributions spanning network pharmacology, metabolomics, and metagenomics. He has authored numerous high-impact SCI publications, including first-author and corresponding-author works in leading journals, reflecting significant influence in his field. His technical expertise includes advanced experimental and analytical methods such as molecular assays, cell and animal studies, and scientific data visualization. His scholarly contributions have been recognized through competitive research funding, patent development, and consistent publication in high-impact journals, underscoring his growing reputation and commitment to advancing pharmaceutical and biomedical research.

Citation Metrics (Google Scholar)

643
480
320
160
0

643

50

11

Citations

Documents

h-index

Jean Noël Nyemb | Medicinal Chemistry | Editorial Board Member

Published on by Top Pharmaceutical

Assist. Prof. Dr. Jean Noël Nyemb | Medicinal Chemistry | Editorial Board Member

The University of Maroua | Cameroon

Assist. Prof. Dr. Jean Noël Nyemb is a distinguished Cameroonian scholar in Organic Chemistry, widely recognized for his contributions to natural products chemistry, medicinal chemistry, and applied chemical sciences. He serves as a Senior Lecturer in the Department of Refining and Petrochemistry at the National Advanced School of Mines and Petroleum Industries, University of Maroua, where he plays a leading role in teaching, research, postgraduate supervision, and curriculum development. Over the course of his academic journey, he has held several positions across respected higher education institutions, including the University of Maroua, the University of Ngaoundere, and the Higher Institute of Science and Technology of Yaounde. His progressive career includes roles as Instructor, Lecturer, Part-time Lecturer, Research Fellow, and ultimately Senior Lecturer, reflecting a consistent record of academic excellence, professional growth, and dedication to scientific advancement.Dr. Nyemb earned his Ph.D. in Organic Chemistry with the highest distinction, specializing in Natural Products Chemistry, following a strong academic foundation that includes graduate and undergraduate degrees in Organic and Applied Chemistry. His scientific expertise covers the isolation, characterization, and structural elucidation of secondary metabolites, the synthesis and semi-synthesis of biologically active compounds, and the evaluation of their pharmacological potential, including antimicrobial, antioxidant, enzyme-inhibitory, and chemotaxonomic relevance. His research further integrates molecular docking, computational drug design, pharmacokinetics, toxicology, enzymology, and biochemistry, illustrating his multidisciplinary approach to discovering bioactive molecules with therapeutic value.With more than forty publications, an impressive cumulative impact factor, and numerous articles as principal or co-author, Dr. Nyemb has established himself as a productive scientist in his field. His works span areas such as phytochemical profiling, medicinal plant research, natural compound synthesis, and biological activity evaluation. His publications are well-cited globally, and his h-index reflects strong scholarly influence. Dr. Nyemb is also actively involved in ongoing research projects focusing on bioactive compounds from Vernonia species and members of the Zingiberaceae family, highlighting his interest in medicinal plants and ethnopharmacological resources.

Citation Metrics (Google Scholar)

500400

300

200

100

0

Citations
487

h-index
11

i10-index
13

Citations
h-index
i10-index


View Google Scholar Profile

Featured Publications

Faiza Abou El-Soud | Formulation Science | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Faiza Abou El-Soud | Formulation Science | Best Researcher Award

College of Nursing-Riyadh King Saud bin Abdulaziz University for Health Sciences | Saudi Arabia

Prof. Faiza Abou El-Soud is a distinguished scholar and nursing educator whose work focuses on advancing health outcomes, improving the quality of patient care, and enriching the academic development of nursing students. With extensive expertise in nursing education, geriatric care, and psychosocial health, Professor Abou El-Soud has built a research portfolio that bridges theoretical understanding with practical application in healthcare and nursing practice. Her scholarly contributions reflect a commitment to evidence-based nursing, patient-centered care, and the empowerment of healthcare professionals through research-driven insights.Among her notable works is Nursing Students’ Perceptions toward Success and Failure Factors and their Academic Performance: A Descriptive Correlational Study, published in SYLWAN, which explores the academic determinants influencing nursing students’ success, offering valuable perspectives for educators seeking to improve nursing education outcomes. Another significant contribution, Impact of Self-Efficacy Theory on Improving Adherence of Older Adults Patients with Glaucoma’s Medication, published in the Journal of Health, Medicine and Nursing, applies psychological theory to practical nursing interventions, highlighting how self-efficacy principles can enhance medication adherence among older adults suffering from glaucoma.Professor Abou El-Soud has also made important contributions to geriatric health and community nursing through her publication Quality of Life, Self-Rated Health and Social Support among Older Adult in the Saudi Community in The Malaysian Journal of Nursing, where she and her co-authors assess the complex interplay between social support, perceived health, and overall life satisfaction among elderly populations. In another influential study, The Relationship between Health-Related Quality of Life and Burden among Family Caregivers of Elderly Patients Undergoing Hemodialysis in Saudi Arabia, published in the International Journal of Nursing Research, she investigates the emotional and physical challenges faced by caregivers, offering actionable insights to enhance support systems and healthcare strategies.Her collaborative work Impact of the Intrinsic and Extrinsic Motivation Factors on the Turnover Intention among Academic Staff, published in the IOSR Journal of Nursing and Health Science, examines motivational dynamics in academic environments and their influence on faculty retention, thereby contributing to the sustainability and advancement of nursing education institutions.

Profile: Google Scholar

Featured Publications

Salama, R. A., & Abou El-Soud, F. A. (n.d.). Caregiver burden from caring for impaired elderly: A cross-sectional study in rural Lower Egypt. Italian Journal of Public Health, 9(4), 103.

AlAnnaz, W. A. A., Gouda, A. D. K., Abou El-Soud, F. A., & Alanazi, M. R. (n.d.). Obesity prevalence and its impact on maternal and neonatal outcomes among pregnant women: A retrospective cross-sectional study design. Nursing Reports, 14(2), 1236–1250.

Hussein, A. A., & El-Soud, F. A. A. (n.d.). Developing an educational intervention and a standardized clinical assessment tool to promote clinical instructors assessment skills. The Fifteenth National Conference Evidence Based Practice.

Shaqiqi, W., & Abou El-Soud, F. A. (n.d.). The mediating role of social support on the relationship between secondary traumatic stress and burnout of nurses caring for COVID-19 patients: A cross-sectional study. Applied Nursing Research, 79, 151844.

Abou El-Soud, F. A., Alhoraim, S. A., Alammar, B. A., & Alotaibi, R. S. (n.d.). Quality of life, self-rated health and social support among older adult in the Saudi community. The Malaysian Journal of Nursing, 11(3), 13–25.

Al-Shehhi, M. S. M., & El-Soud, F. A. A. (n.d.). Factors affecting quality of life in patients with end-stage renal disease on hemodialysis, Ras Al Khaimah – United Arab Emirates. Journal of Health, Medicine and Nursing, 220–238.

Abou-El-Soud, F. A., Mohamed, H. F., & Prince, J. (n.d.). The effectiveness of training workshop in changing the tutors’ knowledge and attitude towards the integration of problem-based learning into nursing curriculum. International Journal of Nursing, 5.

Surya Nandan Meena | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Surya Nandan Meena | Drug Discovery and Development | Best Researcher Award

Dr. Surya Nandan Meena, Savitribai Phule Pune University, India

Dr. Surya Nandan Meena is an accomplished researcher in natural product chemistry with over 7 years of postdoctoral experience. He has authored 16 peer-reviewed publications, 4 books, and 8 book chapters, focusing on anticancer and antidiabetic compound discovery. 🧬 His expertise spans LC-MS/MS, molecular docking, and mammalian cell assays. 🎓 A recipient of prestigious fellowships like the Dr. D.S. Kothari and SERB-DST, he has led international projects, mentored students, and contributed to multidisciplinary science globally. 🌱 Passionate about drug discovery and marine biotechnology, Dr. Meena actively serves on editorial boards and scientific societies worldwide.

Publication Profile

Google Scholar

Education

Dr. Surya Nandan Meena is a dedicated scholar with a robust academic background in biotechnology and agriculture. He earned his Ph.D. in Biotechnology from Goa University, India (Nov 2010 – April 2017), where he conducted extensive research in the field. Prior to that, he completed his M.Sc. in Plant Biotechnology from UAS Dharwad, India (July 2006 – April 2009), further refining his expertise in plant sciences 🌿. His academic journey began with a B.Sc. (Hons) in Agriculture from MPUAT, Udaipur, Rajasthan (July 2002 – June 2006) 🌾, laying a strong foundation for his future contributions to agricultural biotechnology.

Awards

Dr. Surya Nandan Meena has been honored with numerous prestigious awards and research fellowships throughout his academic journey. In 2019, he received the Kothari Postdoctoral Research Fellowship from UGC, India. He earned the Best Research Paper Appreciation Award from Anchrome Pvt. Ltd. in 2018 📜. In 2017, he was awarded the National Postdoctoral Fellowship by SERB-DST, India. His dedication was also recognized with the Senior Research Fellowship from DBT in 2013 and the Best Poster Presentation Award in 2012 🧪. Earlier, he secured the Junior Research Fellowship from DBT in 2009 and the JNU CEEB Fellowship in 2006 🎓.

Experience

Dr. Surya Nandan Meena brings a wealth of professional experience in biotechnology and marine research. Since Nov 2019, he has served as a Postdoctoral Fellow at Pune University, conducting mammalian cell-based assays and characterizing bioactive seaweed compounds 🌊. Earlier, at the National Institute of Oceanography (2017–2019), he surveyed 35+ seaweed species and contributed to multiple publications 📚. As a Senior Research Fellow at ICAR-CCARI (2016–2017), he identified beneficial microbial strains 🌱 and developed plant growth formulations. His roles also included mentoring students, publishing in high-impact journals, and leading interdisciplinary research, reflecting his dedication to scientific innovation and collaboration 👨‍🔬.

Research Focus

Dr. Surya Nandan Meena’s research centers on natural product chemistry, sustainable bioresource utilization, and drug discovery. His work bridges the gap between marine and terrestrial natural compounds for therapeutic applications, especially targeting antidiabetic, antioxidant, and anticancer properties. With notable contributions in biocatalysis, phytochemistry, and biosynthetic pathways, Dr. Meena emphasizes green, solvent-free synthesis and eco-friendly resource management. He actively explores seaweed farming, plant-based compounds, and essential oils as potent sources for novel bioactives. His multidisciplinary approach contributes significantly to natural compound-based drug development and sustainable healthcare innovation.

Publication Top Notes

Natural resources conservation and advances for sustainability

Graphite catalyzed solvent free synthesis of dihydropyrimidin-2 (1H)-ones/thiones and their antidiabetic activity

Seaweed Farming: A Perspective of Sustainable Agriculture and Socio-economic Development

Advances in Biological Science Research: A Practical Approach

Biosynthesis of vanillic acid by Ochrobactrum anthropi and its applications

α-Glucosidase inhibition activity and in silico study of 2-(benzo [d][1, 3] dioxol-5-yl)-4H-chromen-4-one, a synthetic derivative of flavone

Quick Identification of Piperidine Alkaloid from Roots of Grewia nervosa and Their Glucosidase Inhibitory Activity

Antioxidant and antiglycemic properties of macroalgae, an underutilized blue economy bioresource in India

Evaluation of silver-doped indium oxide nanoparticles as in vitro α-amylase and α-glucosidase inhibitors

New horizons in natural compound research

Biodegradation of seafood waste by seaweed-associated bacteria and application of seafood waste for ethanol production

Belal Hijji | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Belal Hijji | Pharmacology | Best Researcher Award

Assist. Prof. Dr. Belal Hijji, Prince Sattam Bin Abdulaziz University, Saudi Arabia

Assistant Professor Dr. Belal Hijji is a distinguished nursing academic with a Ph.D. in Adult Health Nursing from the University of Ulster, UK. He has served in academic and clinical roles across Jordan, Saudi Arabia, Libya, and the UAE. With a strong focus on blood transfusion safety, he has authored books and peer-reviewed articles, including in Journal of Clinical Nursing and Nursing Reports. Dr. Hijji is passionate about nursing education, patient safety, and ethical research, and is fluent in both Arabic and English. He currently teaches at Prince Sattam bin Abdulaziz University, KSA.

Publication Profile

Google Scholar

Education

Assist. Prof. Dr. Belal Hijji is a distinguished academic with a robust background in nursing education and research. He earned his Bachelor of Nursing from Yarmouk University, Jordan (1983–1987), followed by an MSc in Nursing Studies from the University of Manchester, UK (1999–2001), where he conducted a thesis on students’ perceptions of nursing as a career. He later achieved a Ph.D. in Adult Health Nursing from the University of Ulster, UK (2003–2007), focusing on blood transfusion practices among nurses in Abu Dhabi. 🧠 In 2017, he also earned certification in human research participant protection from the NIH.

Awards

Assist. Prof. Dr. Belal Hijji has enriched his professional journey through a variety of specialized training courses. His early learning included managing hypertension and heart failure (1987) and infection control in London (1996). 🏥 He attended the 2nd GCC Seminar on Gerontology in Abu Dhabi (1997) and gained critical appraisal skills in Oxford (2000). He also participated in conferences on healthcare ethics (2002), medical statistics (2004), and qualitative research at the University of Ulster. 📊 His continuous learning extended through webinars on learning psychology (2022) and contributing to the UN Sustainable Development Goals (2022). 🌍 Lifelong learning remains his driving force.

Experience

Assist. Prof. Dr. Belal Hijji has held numerous academic and clinical roles across the Arab world. Since September 2019, he has served as Assistant Professor of Nursing at Prince Sattam bin Abdulaziz University, KSA. 🇸🇦 Previously, he taught at Al Ghad International Colleges (2015–2019), Benghazi University, Libya (2012–2015), and the University of Ha’il (2011–2012). 🏫 Earlier roles include Assistant Professor at Philadelphia University, Jordan (2008–2010). From 1987 to 2005, he worked in diverse clinical and administrative positions within regional ministries of health. 🏥 His leadership also included overseeing scientific affairs and curriculum development. 📘 His dedication to nursing education spans decades.

Research Focus

Assistant Professor Dr. Belal Hijji’s research primarily centers on blood transfusion knowledge and safety among nurses, with a strong emphasis on nursing education, clinical practice, and assessment tools. His studies span diverse healthcare settings in Jordan and the UAE, investigating nurses’ competencies, transfusion practices, and educational gaps. Additionally, he explores the effectiveness of assessment tools like multiple-choice questions and mathematical skills in dosage calculation, highlighting critical aspects of nursing proficiency. Through observational studies and survey research, Dr. Hijji contributes valuable insights into improving patient safety and enhancing nursing curricula.

Publication Top Notes

Knowledge of blood transfusion among nurses

Measuring knowledge of blood transfusion: A survey of Jordanian nurses

Nurses’ practice of blood transfusion in the United Arab Emirates: an observational study

Flaws of multiple choice questions in teacher-constructed nursing examinations: A pilot descriptive study

Trained nurses’ knowledge and practice of oral care on three wards in acute care hospital in Abu Dhabi, UAE

Item Analysis of the Modified Version of the Routine Blood Transfusion Knowledge Questionnaire

Knowledge and practice of blood transfusion: A survey of nurses in Abu Dhabi, United Arab Emirates

An Indispensable Requirement for Medical Dosage Calculation: Basic Mathematical Skills of Baccalaureate Nursing Students

The Science of Multiple-Choice Questions (MCQs)

Lior Zangi | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Lior Zangi | Drug Discovery and Development | Best Researcher Award

Prof. Lior Zangi, Icahn School of Medicine at Mount Sinai, United States

Prof. Lior Zangi is an Associate Professor of Cardiology and Genetics & Genomic Sciences at the Icahn School of Medicine at Mount Sinai, NY. He earned his Ph.D. in Immunology from the Weizmann Institute and completed postdoctoral training at Harvard Medical School. Renowned for his pioneering work in mRNA-based cardiovascular therapies, Prof. Zangi has received prestigious awards including the AHA Postdoctoral Fellowship and an endowed professorship in Cardiovascular Research. He is a founding board member of the Society for RNA Therapeutics and actively contributes to global scientific councils, manuscript reviews, and grant panels.

Publication Profile

Google Scholar

Education

Prof. Lior Zangi 🎓 began his academic journey with a B.Sc. in Biology from the Hebrew University, Givat-Ram, Jerusalem in 2000. He then earned his M.Sc. in Experimental and Developmental Medicine in 2003 from the Hebrew University Hadassah-Medical School under the guidance of Prof. Raphael Gorodetsky. In 2009, he completed his Ph.D. in Immunology at the Weizmann Institute of Science, mentored by Prof. Yair Reisner. 🌿 He continued his training as a postdoctoral fellow at Sheba Medical Center (2009–2010) under Prof. Benjamin Dekel and later at Harvard Medical School (2010–2014) with Professors Derrick Rossi and Kenneth Chien.

Awards

Prof. Lior Zangi 🌟 has earned numerous prestigious honors throughout his career. He received the ASH Travel Award in both 2008 and 2009 🧳, and in 2009, was granted a Postdoctoral Fellowship Award by the Israeli Budgeting Committee and Planning. In 2012, he was honored with both the ISSCR Travel Award and R&D Systems Travel Grant ✈️. His groundbreaking postdoctoral work earned him the AHA Fellowship Award in 2014 🫀. In 2017, he received the Mount Sinai Faculty Idea Prize 🧠, and in 2019, his research on mRNA therapy was recognized as highly influential 📜. In 2023, he was awarded the Endowed Chan Soon-Shiong Professorship in Cardiovascular Research 🏅.

Research Focus

Prof. Lior Zangi is a pioneering researcher in cardiovascular regenerative medicine, with a special focus on modified mRNA therapies, 🧬 stem cell biology, and 🫀 cardiac regeneration. His work centers on developing innovative strategies for repairing damaged heart tissue using modRNA, induced pluripotent stem cells (iPSCs), and heart-on-chip technologies. Zangi’s groundbreaking research has contributed to advancements in treating conditions like myocardial infarction and Barth syndrome, and has broad implications for tissue engineering, 💉 protein replacement therapy, and immune modulation. His contributions are reshaping modern precision medicine and offering new hope for heart failure patients worldwide.

Publication Top Notes

Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction

Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads

Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells

A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells

Isolation and characterization of nontubular sca-1+ lin− multipotent stem/progenitor cells from adult mouse kidney

Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration

mRNA-based protein replacement therapy for the heart

Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction

yang huanzhi | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

yang huanzhi | Pharmacology | Best Researcher Award

Dr. yang huanzhi, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China, China

Dr. Huanzhi Yang is a Ph.D. candidate in Food Science and Engineering at China Agricultural University (2019–2025) 🎓, focusing on food nutrition, natural products, and chronic disease prevention. With a strong academic background from Hunan Agricultural University and Huaihua University, his research spans functional food development, gut health, and antioxidants. He has authored multiple high-impact publications 📝, holds several international patents 🧪, and has collaborated on national food science projects. Recognized for his innovation and excellence, Dr. Yang has received numerous scholarships, awards, and honors 🏆, showcasing his commitment to scientific advancement and food health solutions.

Publication Profile

Scopus

Education

Dr. Yang Huanzhi 🎓 is currently pursuing a Ph.D. in Engineering at China Agricultural University (2019.09–2025.06), specializing in Food Science and Engineering under the guidance of Prof. Xiaojun Liao 🍎. He earned his Master’s degree in Bioengineering from Hunan Agricultural University (2016.09–2018.06), mentored by Prof. Guoping Peng 🧬. Dr. Yang began his academic journey at Huaihua University, where he completed his Bachelor’s degree in Bioengineering (2012.09–2016.06) 📘. With a solid foundation in food and biosciences, his research focuses on advancing food science and nutritional engineering for a healthier future 🌱.

Experience

Dr. Yang Huanzhi’s research focuses on food nutrition and health 🍽️, emphasizing the role of natural products in preventing and controlling chronic diseases 💊. With a passion for improving public well-being, he explores the bioactive components in natural sources 🌿 and their potential in promoting long-term health. His work contributes to the development of functional foods that not only nourish but also serve therapeutic purposes 🥦. By integrating nutritional science with innovative food engineering, Dr. Yang aims to create sustainable, health-promoting dietary solutions for modern lifestyles 🧠❤️. His dedication is shaping the future of preventive nutrition and wellness.

Awards

Dr. Yang Huanzhi has been recognized for his outstanding academic and research achievements 🌟. From 2020 to 2024, he consistently received the “Second Class Scholarship” 🏅 for five consecutive years during his doctoral studies at China Agricultural University. In 2022, he earned the second prize in the 3rd “Xingnong Cup” Innovation and Entrepreneurship Competition 💡. His dedication to safety and responsibility earned him the honorary title of Excellent Laboratory Safety Officer for two consecutive years (2021–2022) 🧪🛡️. Additionally, in 2019, his master’s work was honored with the “Excellent Master’s Thesis” award from Hunan Agricultural University 📜🏆.

Research Focus

Dr. Yang Huanzhi focuses on nutraceuticals, gut microbiota, and inflammation-related diseases. His research delves into how natural plant-based compounds—particularly polyphenols from CiLi (Rosa roxburghii Tratt.)—can modulate the gut microbiota-lipid mediator-immunity axis to alleviate chronic inflammatory conditions such as colitis. 🌿 His work bridges phytochemistry, immunology, and microbiome research, emphasizing the therapeutic potential of functional foods and dietary interventions. 🧫💊 By uncovering the molecular pathways through which CiLi polyphenols influence gut health and immune regulation, Dr. Huanzhi contributes to the advancement of integrative medicine and functional nutrition in disease prevention and treatment.

Publication Top Notes

CiLi (Rosa roxburghii Tratt.) polyphenols improve colitis via gut microbiota-lipid mediator-immunity axis

Dan Yan | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Dan Yan | Pharmacology | Best Researcher Award

Prof. Dan Yan, Beijing Friendship Hospital, Capital Medical University, China China

Prof. Dan Yan is the Director of the Pharmacy Department and Vice Director of the Drug Clinical Trial Institution at Beijing Friendship Hospital, Capital Medical University. A leading expert in intelligent molecular diagnosis and combination therapies for chronic metabolic diseases, he has authored numerous high-impact publications and led national research projects. With a Ph.D. from Chengdu University of Traditional Chinese Medicine and postdoctoral training in cell biology, Prof. Yan also serves on key national academic committees. He work bridges traditional Chinese medicine with modern pharmacology to advance precision healthcare.

Publication Profile

Scopus

Education

Prof. Dan Yan 🎓 has dedicated he academic journey to the field of Traditional Chinese Medicine. He earned he Ph.D. (2004–2007), M.S. (2001–2004), and B.S. (1994–1998) degrees—all from the esteemed Chengdu University of Traditional Chinese Medicine 🏛️. He consistent pursuit of knowledge over the years reflects a deep passion for advancing holistic health and medical science rooted in ancient wisdom 🌿. With a strong foundation in both theoretical and practical aspects of Traditional Chinese Medicine, Prof. Yan continues to contribute significantly to research, education, and innovation in this timeless and evolving discipline 📚🔬.

Experience

Prof. Dan Yan 🌟 has actively served on numerous prestigious academic committees, showcasing he leadership in Traditional Chinese Medicine. Since 2023, he has been recognized as a National High-level Leading Talent 🇨🇳, Director of a Key Discipline under the National Administration of TCM 🏛️, and a recipient of the Chinese Government Special Allowance 🏅. He is also a member of the China National Pharmacopoeia Committee (2022–2027) 📘 and holds leadership roles in institutes focused on clinical pharmacy, precision medicine, and rational drug use 💊📊. He extensive contributions highlight he dedication to advancing science, policy, and international collaboration in healthcare 🌐🧬.

Research Focus

Prof. Dan Yan is a leading researcher in metabolic diseases, particularly focusing on type 2 diabetes, insulin resistance, and gut microbiota 🧫. He research integrates microbiome science, metabolomics, and traditional Chinese medicine🌿 to develop novel therapeutic strategies. He investigates microbial metabolites (e.g., succinate, L-citrulline) and their roles in modulating intestinal immunity🦠 and enhancing drug responses like metformin efficacy💊. He studies also include chemodynamic therapy, biomarker discovery, and machine learning-based screening in diabetes diagnostics 🤖. Prof. Yan’s contributions are reshaping how we understand and manage chronic metabolic disorders on a molecular and systemic level.

Publication Top Notes

Lactobacillus murinus alleviates insulin resistance via promoting L-citrulline synthesis

Function, mechanism of action, metabolism, and commercial application of Lonicera japonica: a review

Coupling Probiotics with CaO2 Nanoparticle-Loaded CoFeCe-LDH Nanosheets to Remodel the Tumor Microenvironment for Precise Chemodynamic Therapy

Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity

Circulating metabolites difference in type 2 diabetes patients from regions: a cross-sectional study

Detecting key genes relative expression orderings as biomarkers for machine learning-based intelligent screening and analysis of type 2 diabetes mellitus

Advances in in vitro assessment models and screening methods for blood glucose-lowering medications

Discovery of the targets and lead compounds of traditional chinese medicine based on the molecular trajectory of diabetes evolution

3D spheroid HepaRG and fluorescent biphasic tracer for CYP3A4-mediated antibiotic interaction monitoring in sepsis

Integrated biomarker profiling for predicting the response of type 2 diabetes to metformin